Related Experiment Video
Updated: May 13, 2026
Synthesis of 68Ga Core-doped Iron Oxide Nanoparticles for Dual Positron Emission Tomography /(T1)Magnetic Resonance Imaging
Published on: November 20, 2018
Engineered iron-oxide-based nanoparticles as enhanced T1 contrast agents for efficient tumor imaging
Zijian Zhou1, Lirong Wang, Xiaoqin Chi
1State Key Laboratory of Physical Chemistry of Solid Surfaces, The Key Laboratory for Chemical Biology of Fujian Province, and Department of Chemical Biology, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, China.
We developed small, zwitterion-coated gadolinium-embedded iron oxide (GdIO) nanoparticles for enhanced tumor imaging. These novel nanoparticles offer improved T1 contrast, efficient tumor targeting, and safe body clearance.
Area of Science:
- Nanotechnology
- Biomedical Imaging
- Materials Science
Background:
- Developing effective T1 contrast agents for magnetic resonance imaging (MRI) is crucial for accurate tumor detection.
- Iron oxide nanoparticles offer potential as contrast agents but often face challenges with circulation time and non-specific protein adsorption.
- Gadolinium-based agents are effective but raise concerns regarding long-term toxicity.
Purpose of the Study:
- To design and synthesize small-sized zwitterion-coated gadolinium-embedded iron oxide (GdIO) nanoparticles.
- To evaluate their efficacy as T1 contrast agents for tumor imaging.
- To assess their pharmacokinetic properties, including circulation half-life and clearance mechanisms.
Main Methods:
- Synthesis of GdIO nanoparticles with controlled size (∼4.8 nm).
- Surface functionalization with zwitterionic dopamine sulfonate molecules.
- Characterization of physicochemical properties, including relaxivity and hydrodynamic size.
- In vivo evaluation of tumor targeting and pharmacokinetic behavior in a xenograft tumor model.
Main Results:
- GdIO nanoparticles exhibited a strong T1 contrast effect with high r1 relaxivity (7.85 mM(-1)·S(-1)) and a low r2/r1 ratio (5.24).
- Zwitterion coating ensured stable hydrodynamic size (∼5.2 nm) and minimized non-specific protein adsorption.
- The nanoparticles demonstrated efficient passive tumor targeting and a circulation half-life of approximately 50 minutes.
- Evidence of rapid renal clearance post-imaging was observed.
Conclusions:
- Small-sized zwitterion-coated GdIO nanoparticles represent a promising platform for sensitive T1-weighted tumor imaging.
- The developed nanoparticles combine enhanced T1 contrast, efficient tumor accumulation, and favorable pharmacokinetic profiles.
- This strategy offers a valuable approach for creating safer and more effective iron-oxide-based MRI contrast agents.
